GE Acquires Amersham for $9.5 Billion
LONDON & FAIRFIELD, Conn., Oct. 10 -- General Electric Co. announced it has agreed to buy British medical diagnostics company Amersham plc for $9.5 billion, subject to regulatory approval and other customary conditions. GE also announced its earnings fell 11 percent in the third quarter, which it attributed to lower gas turbine and aircraft engine sales and an accounting charge that weakened profits. The acquisition followed an announcement earlier this week by GE and French company Vivendi Universal that they would merge Vivendi's Hollywood studio, cable TV networks and theme parks with GE's NBC business.
Jeffrey R. Immelt, chairman and CEO of General Electric, said Amersham will supplement GE Medical's diagnostic imaging, services and health care information technology businesses and that it will help GE accelerate the development of molecular imaging.
After the acquisition, Amersham CEO William Castell will become a GE vice chairman and board member and will have responsibility for GE Healthcare Technologies, the combined Amersham and GE Medical businesses. Joseph Hogan, senior vice president of GE, will continue to lead the GE Medical business. The GE Healthcare Technologies business will be based in the UK.
For more information, visit: www.ge.com
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024